CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Cash Flows From Operating Activities:
Net loss	$ (1,417,870)	$ (1,054,941)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization of property and equipment	1,726	939
Amortization of customer contracts	131,250	14,583
Amortization of notes payable discount	4,787	0
Fair value of common stock issued under Employment Settlement Agreement	0	50,000
Non-cash interest income related to discount accretion	0	(5,305)
Goodwill impairment loss	48,158	0
Stock-based compensation expense	417,334	0
Restricted stock award expense	4,167	0
Changes in operating assets and liabilities:
Accounts receivable	173,202	(126,351)
Inventory and work in process	0	673
Deposits, prepaid expenses and other assets	49,789	(10,512)
Accounts payable	303,992	500,617
Accrued expenses and other current liabilities	(24,746)	(14,775)
Accrued compensation	80,000	(10,000)
Net Cash Used In Operating Activities	(228,211)	(655,072)
Cash Flows From Investing Activities:
Cash acquired in reverse acquisition	0	93,416
Purchase of equipment	(34,100)	(10,391)
Net Cash (Used) Provided In Investing Activities	(34,100)	83,025
Cash Flows From Financing Activities:
Proceeds from issuance of notes payable and common stock warrants	214,300	0
Principal paid on notes payable	(25,500)	0
Proceed from issuance of Preferred Stock - Series E	0	150,000
Proceeds from issuance of common stock	34,640	515,000
Net Cash Provided By Financing Activities	223,440	665,000
Net Change in Cash and Cash Equivalents	(38,871)	92,953
Cash and Cash Equivalents - Beginning of Period	50,598	59,597
Cash and Cash Equivalents - End of Period	11,727	152,550
Supplemental Disclosures Of Cash Flow Information:
Interest paid	7,015	0
Income taxes paid	0	0
Non-Cash Investing and Financing Activities:
Note payable issued by AccelPath, LLC for repurchase of common stock	0	74,000
Fair value of common stock warrants issued with convertible notes payable	40,780	0
Fair value of common stock issued under the Equity Purchase Agreement recorded as deferred financing costs	0	36,000
Deferred financing costs charged to additional paid-in capital	(36,000)	0
Preferred Stock-Series E converted to common stock	100,000	0
Cash dividend accrued on Preferred Stock-Series E	$ 10,833	$ 563